BHST (BioHarvest Sciences) EPS (Basic): $-0.58 (TTM As of Mar. 2026)

What is BioHarvest Sciences EPS (Basic)?

BioHarvest Sciences BHST -1.42% 63 EPS (Basic) is $-0.58 as of Mar. 2026. GuruFocus rates BHST with a GF Score™ of 63/100 and a GF Value™ of $8.57 (Possible Value Trap). The stock has 4 warning signs investors should review.

BioHarvest Sciences's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was $-0.11. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.58.

BioHarvest Sciences's EPS (Diluted) for the three months ended in Mar. 2026 was $-0.11. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.58.

BioHarvest Sciences's EPS without NRI for the three months ended in Mar. 2026 was $-0.11. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was -0.58.

During the past 3 years, the average EPS without NRI Growth Rate was 12.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was 2.40% per year. During the past 10 years, the average EPS without NRI Growth Rate was -2.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 12 years, BioHarvest Sciences's highest 3-Year average EPS without NRI Growth Rate was 41.50% per year. The lowest was -78.10% per year. And the median was -5.50% per year.

BioHarvest Sciences (NAS:BHST) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

BioHarvest Sciences EPS (Basic) Related Terms

BioHarvest Sciences EPS (Basic) Historical Data

* Premium members only.

The historical data trend for BioHarvest Sciences's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioHarvest Sciences EPS (Basic) Chart

BioHarvest Sciences Annual Data

Trend

Apr16

Apr17

Apr18

Apr19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

EPS (Basic)

Get a 7-Day Free Trial

-0.70

-0.93

-0.80

-0.60

BioHarvest Sciences Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
EPS (Basic)	Get a 7-Day Free Trial															-0.13	-0.24	-0.14	-0.09	-0.11

63GF Score

BioHarvest Sciences Inc BHST

EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

BioHarvest Sciences EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

BioHarvest Sciences's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-11.135	-	0)	/	18.411
	=	-0.60

BioHarvest Sciences's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-2.641	-	0)	/	22.667
	=	-0.12

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.58

Frequently Asked Questions Learn more about EPS (Basic) →

What does a EPS (Basic) of $-0.58 mean?

BioHarvest Sciences (BHST) has a EPS (Basic) of $-0.58 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on BioHarvest Sciences and its competitors.

Is BioHarvest Sciences' EPS (Basic) too high?

BioHarvest Sciences' current EPS (Basic) is $-0.58. Overall, BioHarvest Sciences has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does BioHarvest Sciences' EPS (Basic) compare to GWLL and CLNN?

BioHarvest Sciences' EPS (Basic) of $-0.58 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EPS (Basic) for a Consumer Packaged Goods company?

A good EPS (Basic) depends on the Consumer Packaged Goods industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EPS (Basic) mean?

A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on BioHarvest Sciences and its competitors. BioHarvest Sciences's current EPS (Basic) is $-0.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is BioHarvest Sciences stock overvalued right now?

Based on GuruFocus' analysis, BioHarvest Sciences (BHST) is currently considered Possible Value Trap. The stock's GF Value™ is $8.57, compared to a current price of $2.77 — trading 67.7% below its estimated fair value. The current EPS (Basic) is $-0.58. BioHarvest Sciences' overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EPS (Basic) calculated?

EPS (Basic) is calculated from a company's financial statements. For BioHarvest Sciences (BHST), the current EPS (Basic) is $-0.58 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioHarvest Sciences (BHST) Overvalued in 2026?

Based on GuruFocus' analysis, BioHarvest Sciences stock appears to be undervalued. The current stock price of $2.77 is trading 67.7% below its estimated GF Value™ of $8.57. GuruFocus considers BioHarvest Sciences to be Possible Value Trap.

Key valuation signals for BHST:

EPS (Basic): $-0.58
GF Value™: $8.57 vs. price of $2.77 (67.7% below fair value)
GF Score™: 63/100 with 4 warning signs

No single metric tells the full story. See the BHST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BioHarvest Sciences Business Description

Industry Consumer Defensive Consumer Packaged Goods

Comparable Companies GWLL CLNN FTLF LFVN BRID HAIN SRXH DDC UMEW BOF XSWX:NESN XPAR:BN BOG:NUTRESA TSE:2802 SHSE:603288 NSE:NESTLEIND KHC SHSE:600887 SZSE:300999 GIS

Other Exchanges 8MV0:Germany

Address 1140-625 Howe Street, Vancouver, BC, CAN, V6C 2T6

Website https://www.bioharvest.com

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.

63GF Score

Get the complete analysis for BHST

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.77

Price

$8.57

GF Value

View BHST Analysis

See EPS (Basic) data for all stocks →